The first long-term comparison of psilocybin vs an SSRI for MDD suggests the psychedelic was associated with better overall ...

Transportation and geographic location are two of the biggest barriers to mental health care access for older adults. This ...

A study comparing psilocybin to the SSRI escitalopram found both drugs improved depressive symptoms similarly over six months ...

This study aimed to explore the association between major depressive disorder (MDD) and suicide risk in dementia patients.A cohort of 625,218 individuals aged ≥40 years with dementia between 2007 and ...

Expert opinion from Ilya Aleksandrovskiy M.D., MBA · 5 years of experience · USA According to research, depression is not ...

Oral and poster presentations of results from Study 501 evaluating lumateperone 42 mg as an adjunctive therapy to antidepressants for the ...

STIM recently announced that additional payors have updated the coverage of TMS (transcranial magnetic stimulation). This upgrade is aimed at reducing the access barriers for patients with major ...

Pediatric patients are also more susceptible to becoming addicted to ketamine and forming substance abuse disorders.

Researchers applied machine learning to predict depressive symptoms, revealing sleep quality and anxiety as key factors ...

Hoarding Disorder is classified under the category of Obsessive-Compulsive and Related Disorders in the DSM-5. It has gained ...

RIM-TD open-label extension (OLE) study showed long-term improvement of Tardive Dyskinesia (TD) symptoms from treatment with deutetrabenazine ...

Oral and poster presentations of results from Study 501 evaluating lumateperone 42 mg as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) ...